Skip to content

Cannabis for addiction: all studies

Page 6 of 9: studies 51 to 60 of 88, newest first. Back to the cannabis for addiction overview

Research

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

Frontiers in Psychiatry January 22, 2020 Earth Erowid, Fire Erowid, Albert Garcia‐romeu et al. 155 citations

While these cross-sectional and self-report methods cannot determine whether psychedelics caused changes in drug use, results suggest the potential that psychedelics cause reductions in problematic substance use, and support additional clinical research on psychedelic-assisted treatment for SUD.

[Dependence and Cytotoxicity of Components of Cannabis].

Yakugaku Zasshi 2020 Masahiko Funada, Ken-Ichi Tomiyama

Cannabis use among the younger population in Japan has been steadily increasing. The aim of the present review is to highlight recent knowledge regarding the molecular mechanisms of action and health risks associated with cannabis and synthetic cannabinoid consumption. We investigated the effects of Δ9-tetrahydrocannabinol (THC) and synthetic cannabinoids on place conditioning in ICR mice. Both...

New psychoactive substances and the risks of consumption in children and adolescents

Romanian Journal of Pediatrics December 31, 2019 Viorela Nitescu 4 citations

According to the definition established by the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) a “new psychoactive substance is considered any narcotic or psychotropic substance in pure form or in preparations, which is not controlled by the Conventions regarding drugs of the United Nations and which represent a threat to human health comparable to that realized by the...

The neuropsychopharmacology of cannabis: A review of human imaging studies

Pharmacology & Therapeutics October 20, 2018 Michael Bloomfield, Chandni Hindocha, Sebastian F Green et al. 236 citations

receptor. Acutely, cannabis and THC produce a range of effects on several neurocognitive and pharmacological systems. These include effects on executive, emotional, reward and memory processing via direct interactions with the endocannabinoid system and indirect effects on the glutamatergic, GABAergic and dopaminergic systems. Cannabidiol, a non-intoxicating cannabinoid found in some forms of...

Highway to hell or magic smoke? The dose-dependence of Δ9-THC in place conditioning paradigms.

Learning & Memory September 2018 Rimas A Kubilius, Paul M Kaplick, Carsten T. Wotjak preprint

The prerequisites for responsible cannabis use are at the heart of current inquiries into cannabis decriminalization by policy makers as well as academic and nonacademic stakeholders at a global scale. Δ9-tetrahydrocannabinol (Δ9-THC), the prime psychoactive compound of the cannabis sativa, as well as cannabimimetics that resemble the pharmacological properties and psychological effects of...

Different effects of chronic THC on the neuroadaptive response of dopamine D2/3 receptor-mediated signaling in roman high- and roman low-avoidance rats.

Synapse April 2018 Benjamin B Tournier, Andrea Dimiziani, Stergios Tsartsalis et al.

The Roman high (RHA)- and low (RLA)-avoidance rat sublines have been identified as an addiction-prone and addiction-resistant phenotype based on their high vs. low locomotor responsiveness to novelty and high vs. low ability to develop neurochemical and behavioral sensitization to psychostimulants, respectively. Most studies though have focused on psychostimulants and little is known about the...

Subcortical Local Functional Hyperconnectivity in Cannabis Dependence

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging November 23, 2017 Peter Manza, Dardo G. Tomasi, Nora D. Volkow 61 citations

BACKGROUND: Cannabis abuse (CA) has been associated with psychopathology, including negative emotionality and higher risk of psychosis, particularly with early age of initiation. However, the mechanisms underlying this association are poorly understood. Because aberrant dopamine signaling is implicated in cannabis-associated psychopathology, we hypothesized that regular CA would be associated...

New Psychoactive Substances (NPS) – a Challenge for the Addiction Treatment Services

Pharmacopsychiatry April 25, 2017 Norbert Scherbaum, Fabrizio Schifano, Udo Bonnet 46 citations

Over the last few years, hundreds of new psychoactive substances (NPS) have been identified in Europe. Apart from some herbal compounds, NPS mainly include synthetic cannabinoids and a range of new synthetic stimulants (e. g., cathinones). Synthetic NPS are often developed whilst modifying the basic chemical (e. g., phenethylamine or tryptamine) structure. Although the pharmacology and...

DOI: 10.1055/s-0043-102059 (opens in new tab) Cannabis Addiction Synthetic cannabinoids Designer drug +3

New psychoactive substances of natural origin: A brief review

Journal of Food and Drug Analysis April 18, 2017 Ling‐yi Feng, Altansuvd Battulga, Eunyoung Han et al. 86 citations

Plant-based drugs of abuse are as old as recorded human history. Although traditional addictive substances, such as opium, cannabis and coca, have been controlled by the United Nations anti-drug conventions, many, if not most, natural plants with addictive or abuse liability remain elusive. Therefore, the United Nations Office on Drugs and Crime (UNODC) has warned the emerging threat from new...

Aleister Crowley on Drugs

International Journal for the Study of New Religions February 20, 2017 Christopher Partridge 1 citation

While much has been written about the life, work and influence of Aleister Crowley, relatively little attention has been directed to his drug use. This is a little surprising because, not only did he become addicted to heroin, but he incorporated psychoactive substances in his occult work, discussed their psychological effects, commented on drug-related social issues, critiqued contemporary...